XTNT
Income statement / Annual
Last year (2023), Xtant Medical Holdings, Inc.'s total revenue was $91.30 M,
an increase of 57.50% from the previous year.
In 2023, Xtant Medical Holdings, Inc.'s net income was $660,000.00.
See Xtant Medical Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$91.30 M
|
$57.97 M
|
$55.26 M
|
$53.34 M
|
$64.68 M
|
$72.20 M
|
$82.61 M
|
$90.00 M
|
$59.35 M
|
$35.33 M
|
| Cost of Revenue |
$35.84 M |
$25.83 M |
$22.77 M |
$18.95 M |
$22.17 M |
$28.72 M |
$32.51 M |
$27.71 M |
$20.26 M |
$13.03 M |
| Gross Profit |
$55.47 M |
$32.14 M |
$32.49 M |
$34.39 M |
$42.52 M |
$43.49 M |
$50.10 M |
$62.29 M |
$39.08 M |
$22.30 M |
| Gross Profit Ratio |
0.61 |
0.55 |
0.59 |
0.64 |
0.66 |
0.6 |
0.61 |
0.69 |
0.66 |
0.63 |
| Research and Development
Expenses |
$1.34 M
|
$915,000.00
|
$870,000.00
|
$657,000.00
|
$932,000.00
|
$1.70 M
|
$2.44 M
|
$3.41 M
|
$2.55 M
|
$1.44 M
|
| General & Administrative
Expenses |
$25.85 M
|
$15.46 M
|
$14.45 M
|
$13.50 M
|
$17.94 M
|
$13.00 M
|
$15.33 M
|
$16.03 M
|
$13.24 M
|
$9.02 M
|
| Selling & Marketing
Expenses |
$38.44 M
|
$22.52 M
|
$21.03 M
|
$20.98 M
|
$25.84 M
|
$32.06 M
|
$40.51 M
|
$44.06 M
|
$28.73 M
|
$16.91 M
|
| Selling, General &
Administrative Expenses |
$64.29 M
|
$37.98 M
|
$35.47 M
|
$34.49 M
|
$43.78 M
|
$45.06 M
|
$55.84 M
|
$60.09 M
|
$41.97 M
|
$25.93 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$58,000.00 |
$3,000.00 |
-$74,709.00 |
-$351,914.00 |
$388,176.00 |
-$318,836.00 |
| Operating Expenses |
$65.63 M |
$38.89 M |
$36.34 M |
$35.14 M |
$44.77 M |
$50.88 M |
$63.77 M |
$68.44 M |
$48.34 M |
$27.65 M |
| Cost And Expenses |
$101.46 M |
$64.72 M |
$59.12 M |
$54.09 M |
$66.94 M |
$79.60 M |
$96.28 M |
$96.15 M |
$68.60 M |
$40.68 M |
| Interest Income |
$149,000.00 |
$31,000.00 |
$995,000.00 |
$5.98 M |
$5.77 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$2.94 M |
$1.69 M |
$995,000.00 |
$5.98 M |
$5.77 M |
$10.15 M |
$14.70 M |
$12.26 M |
$7.73 M |
$5.66 M |
| Depreciation &
Amortization |
$3.17 M
|
$1.30 M
|
$1.34 M
|
$2.10 M
|
$3.20 M
|
$5.74 M
|
$8.39 M
|
$7.24 M
|
$4.89 M
|
$952,320.00
|
| EBITDA |
-$6.98 M
|
-$5.43 M
|
-$2.51 M
|
$1.33 M
|
$850,000.00
|
-$54.22 M
|
-$29.31 M
|
$61,434.00
|
-$7.09 M
|
-$3.90 M
|
| EBITDA Ratio |
-0.08 |
-0.09 |
-0.05 |
0.02 |
0.01 |
-0.01 |
-0.06 |
0.01 |
-0.07 |
-0.13 |
| Operating Income Ratio
|
-0.11
|
-0.12
|
-0.07
|
-0.01
|
-0.04
|
-0.83
|
-0.46
|
-0.08
|
-0.2
|
-0.18
|
| Total Other
Income/Expenses Net |
$9.12 M
|
-$1.66 M
|
-$995,000.00
|
-$5.98 M
|
-$5.87 M
|
-$10.02 M
|
-$14.58 M
|
-$11.90 M
|
-$7.63 M
|
-$4.24 M
|
| Income Before Tax |
-$1.04 M |
-$8.42 M |
-$4.85 M |
-$6.73 M |
-$8.12 M |
-$70.10 M |
-$52.41 M |
-$19.44 M |
-$19.71 M |
-$10.51 M |
| Income Before Tax Ratio
|
-0.01
|
-0.15
|
-0.09
|
-0.13
|
-0.13
|
-0.97
|
-0.63
|
-0.22
|
-0.33
|
-0.3
|
| Income Tax Expense |
-$1.70 M |
$69,000.00 |
$995,000.00 |
$296,000.00 |
$98,000.00 |
$124,000.00 |
$14.63 M |
$50,362.00 |
-$17.54 M |
$5.34 M |
| Net Income |
$660,000.00 |
-$8.49 M |
-$5.84 M |
-$7.02 M |
-$8.22 M |
-$70.10 M |
-$52.41 M |
-$19.49 M |
-$2.17 M |
-$10.51 M |
| Net Income Ratio |
0.01 |
-0.15 |
-0.11 |
-0.13 |
-0.13 |
-0.97 |
-0.63 |
-0.22 |
-0.04 |
-0.3 |
| EPS |
0.0055 |
-0.0902 |
-0.0684 |
-0.25 |
-0.62 |
-5.97 |
-34.76 |
-18.46 |
-2.62 |
-19.26 |
| EPS Diluted |
0.0052 |
-0.0902 |
-0.0684 |
-0.25 |
-0.62 |
-5.93 |
-34.51 |
-18.32 |
-2.62 |
-19.26 |
| Weighted Average Shares
Out |
$119.09 M
|
$94.09 M
|
$85.46 M
|
$28.50 M
|
$13.16 M
|
$11.74 M
|
$1.51 M
|
$1.06 M
|
$829,709.00
|
$545,553.00
|
| Weighted Average Shares
Out Diluted |
$126.79 M
|
$94.09 M
|
$85.46 M
|
$28.50 M
|
$13.16 M
|
$11.83 M
|
$1.52 M
|
$1.06 M
|
$829,709.00
|
$545,553.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
